Sign In

Americas

Nippon Life plays up Japan Inc’s existential angst

11 Dec 2024

The insurer is buying smaller US rival Resolution for $8.2 bln. Returns look low, and the weak yen makes overseas purchases more expensive. But the deal diversifies earnings too reliant on a shrinking home market. Assuming Washington allows, such transactions will keep flowing.

Buyout barons’ Europe bargain hunt will intensify

11 Dec 2024

Preqin data shows that funds focusing on the region are outperforming North American ones, helped in part by a 10% valuation discount on local deals. The gap may grow as US stocks get more expensive. But for Europe it’s a sign of corporate weakness, rather than strength.

Blocked grocery mega-merger tips rolling M&A cart

10 Dec 2024

A US judge ruled Kroger’s $25 bln union with Albertsons is anticompetitive, siding with President Biden’s trustbusters. The decision further ingrains some of their bolder ideas. Dealmakers and CEOs planning shopping sprees under a new administration could use the reality check.

Hershey would be a bitter confection to swallow

10 Dec 2024

The Reese’s chocolatier may again be a takeover target for Cadbury owner Mondelez. Anti-obesity drugs and the recent Mars-Kellanova merger make the 2016 idea worth reconsidering. Financing a $50 bln deal will be tough, however, requiring dubiously huge synergies to justify.

How the world could unplug from China’s batteries

10 Dec 2024

International cell makers are struggling to compete with Chinese giants like CATL. But innovations like solid-state batteries could upend the industry in the not-too-distant future. In this week’s episode of The Big View podcast, QuantumScape CEO Siva Sivaram explains how.

Nvidia probe lets China have cake and eat it

10 Dec 2024

Beijing has started an antitrust investigation into the $3.4 trln firm. Coming after more US tech curbs on the country, the motive seems political. But Nvidia's AI chip dominance means monopoly concerns can't be dismissed. And the decision may resonate with regulators elsewhere.

A $13 bln cash sale breaks buyout doom loop

9 Dec 2024

In a tough market for M&A and IPOs, private equity shops have been recycling assets to sate anxious investors. GTCR’s deal to offload its insurance broker to Arthur J. Gallagher provides a sign that the tide may be turning. Whether animal spirits will persist is the question.

Madison Avenue’s $13 bln deal lacks creative spark

9 Dec 2024

Omnicom is buying rival Interpublic to create the largest ad network, with agencies including BBDO and McCann. Chunky savings worth nearly $6 bln help the merger stack up financially. As AI threatens to upend the industry, however, it’s hard to spin it as anything but defensive.

Syrian regime change puts focus on Trump and Iran

9 Dec 2024

The overthrow of President Bashar al-Assad is the latest setback for his supporters in Tehran. President-elect Donald Trump had already pledged to get tougher on the Islamic Republic. Its weakness may embolden him further, with volatile results for the region and the oil price.

Putin faces hard choices if Ukraine war drags on

9 Dec 2024

Though Russia can probably keep fighting for a long time, the costs will mount – especially if inflation rises or the oil price falls. A credible Western plan to support Kyiv could bring President Vladimir Putin to the negotiating table and help secure a decent ceasefire.

Funky fiscal years are long out of date

6 Dec 2024

Comparing the financial results of Apple, Microsoft and Nvidia takes special care. All end in different months and none on the calendar year. Seasonality and inertia are lame excuses to stick with arcane reporting periods. Investors are up against more than enough complexity.

Global carmakers redefine success in China

6 Dec 2024

GM is shrinking to mediocrity with a rejig and roughly $3 bln writedown on the value of its Chinese joint ventures. International brands once chased chunky sales in the People’s Republic, now they aim for profitability on a smaller scale - and to learn from local peers.

US market juggernaut poses top risk for 2025

6 Dec 2024

After a second year of world-beating returns, stocks listed in the United States account for 67% of global equity markets. Outperformance sucks in more capital and companies. Though it’s a long-term trend, US valuations seem high. A reversal would leave few investors unscathed.

UnitedHealth tragedy opens deep healthcare wounds

5 Dec 2024

The murder of insurance boss Brian Thompson drew a slew of callous responses, including on a company Facebook post. Industry profit is rising in a nation spending double its peers on healthcare for worse outcomes. Policy ideas are weak, but political risk is amping up.

Tariff turnabouts send US corporate heads spinning

5 Dec 2024

Donald Trump has threatened import levies ranging from 10% to 100% on Mexico, China, South Africa and everywhere in between. Based on recent earnings calls, CEOs see the president-elect’s gyrations as negotiating tactics. They’ll nevertheless be forced to prepare for the worst.

Drugmakers brace for US political side effects

5 Dec 2024

Donald Trump’s health agency nominee, Robert Kennedy, brings dangerous views on vaccines as well as skepticism about sky-high medicine prices. In this week’s Viewsroom, Breakingviews columnists discuss the impact on giants like Novo Nordisk and how other countries might react.

Japan’s virtuous M&A circle starts with 7-Eleven

5 Dec 2024

The battle for control of $45 bln convenience store owner Seven & i is being cheered in Tokyo. It’s evidence of progress in the drive to improve efficiencies in the world’s third-largest economy. It could also be a sign of what’s to come if officials make the right next moves.

Crypto gets quick return on US election investment

4 Dec 2024

SEC chair nominee Paul Atkins would give the industry an ally with a lighter enforcement touch. The choice helps justify $200 mln of campaign funding and a nearly 60% jump in the value of bitcoin and its ilk. Lax oversight, however, raises the risk of another FTX-like crisis.

Brookfield’s simpler structure adds layer of rigor

4 Dec 2024

The $100 bln investment shop is nearly finished rearranging its sprawling standalone units, helping narrow a stubborn discount to asset value. Hedge fund manager Bill Ackman is a big believer. The new challenge for boss Bruce Flatt will be returns depending purely on performance.